Syverson Strege & Co’s Tenet Healthcare THC Stock Holding History

Syverson Strege & Co’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-211	Closed	-$11K	–	333
2022 Q2	$11K	Buy	+211	New	+$14.7K	﹤0.01%	219

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

CCA

Canyon Capital Advisors Dallas, Texas $882M AUM 62.77% 1-Year Est. Return

Syverson Strege & Co's THC Position: Q3 2022 in Review

Syverson Strege & Co sold out of Tenet Healthcare (THC) in Q3 2022, closing a stake of 211 shares — an estimated $11K sold.

Syverson Strege & Co first reported a position in THC in Q2 2022 and held it in 1 quarter. The position peaked at $11K in Q2 2022. 360 funds tracked by Wall St. Rank hold THC as of Q3 2022.

Syverson Strege & Co reported no remaining Tenet Healthcare position as of Q3 2022 after selling out during the quarter.
Syverson Strege & Co sold 211 Tenet Healthcare shares in Q3 2022, an estimated $11K.
Syverson Strege & Co first reported a position in Tenet Healthcare in Q2 2022 and held it in 1 quarter.
Syverson Strege & Co's Tenet Healthcare position peaked at $11K in Q2 2022.
360 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2022.

Based on Syverson Strege & Co's 13F filing for Q3 2022, filed 9 Nov 2022.